Company Introduction
A bio company owning antibody fragment-based technology and development innovative biologics
Name Experience Remarks
CEO/CTO
Sang Hoon Cha

Currently, Professor, Medical and Bioscience College, Gangwon University

Currently, CEO, April Bio Co., Ltd.

Previously, CEO, IG Therapy Co., Ltd.

Previously, Exchange Professor, Pediatrics Department, Medical College, Singapore National University

Previously, Counselor in charge of Immunology at Macrogen Co., Ltd.

Dr. of Immunology (US, California Univ.)
CDO
Moo Yong Song

Currently, Head of April Bio Research and Planning Division

Previously, Former Yuhan Corp. Central Research Institute / Bio CMC Team Leader (Director)

Doctor of Genetic Engineering
CSO
Seung Gu Gang

Currently, Professor, Medical and Bioscience College, Gangwon University

Currently, CSO, April Bio Co., Ltd.

Previously, Scripps Research Institute / Researcher

Previously, Postdoctoral Fellow, Purdue University

Dr. of Immunology (Pathology) (US, Purdue Univ.)
CBO
Jae Heung Lee

Currently, Director, R&D Division, April Bio Co., Ltd.

Previously, Associate Executive Director, Akizen Biotech Co., Ltd.

Previously, Director, Licensing, Research and Planning Department, KT&G Bioscience Co., Ltd.

Previously, Head of Clinic Development Team/Global Business Team, Isu Abxis Co., Ltd.

Previously, Research Fellow, Bio Engineering Institute, Samyang Genex Co., Ltd.

Pharmacist
CFO
Jin Taek Kim

Currently, Director, Administration Division, April Bio Co., Ltd.

Previously, Director, Administration Division, Castelbajac Co., Ltd.

* Succeeded and took charge of the IPO (2019) of Castelbajac Co., Ltd.

Previously, Head of Planning/Legal Affairs, Office of Planning and Coordination, Fashion group hyungji

Previously, Office of Strategy and Planning, Savezone I&C